SML1949
Synta66
≥98% (HPLC)
别名:
4-吡啶甲酰胺, N-(2′,5′-二甲氧基[1,1′-联苯] -4-基）-3-氟-, GSK1349571A, N-(2′,5′-二甲氧基[1,1′-联苯]-4-yl)-3-氟-4-吡啶甲酰胺, S66, Synta 66, Synta-66
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Quality Level
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C(NC1=CC=C(C2=C(OC)C=CC(OC)=C2)C=C1)C3=CC=NC=C3F
InChI key
GFEIWXNLDKUWIK-UHFFFAOYSA-N
Application
Synta66已用作：
- 作为Ca2+释放激活钙 (CRAC)通道抑制剂，研究其对 ORAI 异构体的影响
- 作为ORAI1阻断剂，研究其对Ca2+进入慢性淋巴细胞白血病(CLL) B细胞的影响
- 作为CRAC阻断剂，研究其对釉质细胞中钙库操纵性Ca2+内流(SOCE)的影响
Biochem/physiol Actions
Synta66（S66）是一种 CRAC（Ca2+ 释放激活型 Ca2+）通道抑制剂，可通过毒胡萝卜素抑制人血管平滑肌细胞（VSMC）中细胞内钙库的 Ca2+ 耗尽，从而高效地阻断 SOCE（钙库操纵性钙内流）（IC50 = 26nM & 43 nM，分别基于最大 Ca2+ 水平 & 增加率）。Synta66 对一系列受体和离子通道（例如 L 型 Ca2 + 通道）没有亲和力，并且不影响 TRPC1/5 介导的 SOCE 或钙库操纵性非选择性阳离子电流。据报道，白细胞对 Synta66 对 CRAC 的抑制作用较不敏感（IC50 = 1.76 μM/HL-60、1 µM/Jurkat，1.4 μM/大鼠 RBL）。
一种选择性的 SOCE 抑制剂，可阻止 CRAC 电流（ICRAC），而没有明显的脱靶效价或亲和力。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Jing Li et al.
British journal of pharmacology, 164(2), 382-393 (2011-05-07)
The aim was to advance the understanding of Orai proteins and identify a specific inhibitor of the associated calcium entry mechanism in vascular smooth muscle cells (VSMCs). Proliferating VSMCs were cultured from human saphenous veins. Intracellular calcium was measured using
Antonio Di Sabatino et al.
Journal of immunology (Baltimore, Md. : 1950), 183(5), 3454-3462 (2009-08-04)
Prolonged Ca(2+) entry through Ca(2+) release-activated Ca(2+) (CRAC) channels is crucial in activating the Ca(2+)-sensitive transcription factor NFAT, which is responsible for directing T cell proliferation and cytokine gene expression. To establish whether targeting CRAC might counteract intestinal inflammation, we
Marjolaine Debant et al.
Journal for immunotherapy of cancer, 7(1), 111-111 (2019-04-25)
Dysregulation in calcium (Ca2+) signaling is a hallmark of chronic lymphocytic leukemia (CLL). While the role of the B cell receptor (BCR) Ca2+ pathway has been associated with disease progression, the importance of the newly described constitutive Ca2+ entry (CE)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML1949-5MG | 04061832964249 |
| SML1949-25MG | 04061832964232 |